FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstaZeneca

Released
2025-06-09 21:30
  • business news
  • news
  • web article

Read more on www.cnbc.com

Picture from image.cnbcfm.com

Related items

Published by

CNBC

In one list